Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 14/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17425467 | 1.00 | PDK2 (0.44) | PDK2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL18539304 | 1.00 | PDK2 (0.44) | PDK2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL17425464 | 1.00 | PDK2 (0.44) | PDK2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL30022839 | 1.00 | PDK2 (0.44) | PDK2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL17425571 | 1.00 | PDK2 (0.44) | PDK2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL21319075 | 0.99 | PDK2 (0.43) | PDK2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL17425471 | 0.99 | PDK2 (0.43) | PDK2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL30020900 | 0.99 | PDK2 (0.42) | PDK2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL17425465 | 0.99 | PDK2 (0.42) | PDK2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL26572199 | 0.97 | PDK2 (0.43) | PDK2MEN1KMT2AALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210074925-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-03-11 | — | — | US | disclosed |
| US-20170148995-A1 | ORGANIC LIGHT EMITTING DISPLAY DEVICE | LG DISPLAY CO., LTD. (KR) | 2017-05-25 | — | — | US | disclosed |
| US-20170148995-A1 | ORGANIC LIGHT EMITTING DISPLAY DEVICE | LG DISPLAY CO., LTD. (KR) | 2017-05-25 | — | — | US | disclosed |
| US-20160346270-A1 | BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 | AUSPEX PHARMACEUTICALS, INC. | 2016-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160346270-A1 | BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 | SLC18A2, SLC6A2, SLC18A1 | PDK2 396/4885MEN1 3213/4885KMT2A 626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.